In AD, FUNDC1 and its multiple phosphorylated kinases and other key molecules involved in its regulation not only affect the phosphorylation of Tau proteins and the metabolic process of Aβ but may also exacerbate the decline of cognitive functions and promote the progression of AD through multiple downstream signaling pathways. The gene discussed is MAPT; the disease is Alzheimer disease.